Overview / Abstract: |
Many atherosclerotic cardiovascular disease (ASCVD) patients do well after suffering a heart attack or stroke, but frequently, these patients continue to be at high risk for recurrent cardiovascular events and are not necessarily stable. It is important to understand the patients, particularly those with polyvascular disease, at higher risk for recurrent events. Are you current with how to best manage these patients? Find out in this short vlog, where Dr. Christian Ruff from Brigham and Women's and Harvard Medical School, discusses the COMPASS trial and its implications for patients with stably unstable polyvascular disease. The purpose of this activity is to provide learners with an engaging, concise presentation to help them optimize anticoagulant therapy in their patients with polyvascular disease. Learners post-activity will also be better able to interpret the latest data on DOACs as for patients with stably unstable ASCVD. |
Expiration |
Jun 18, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
.25 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Christian T. Ruff, MD, MPH |
Activity Specialities / Related Topics |
Cardiology / Cardiovascular, Family Medicine, Primary Care |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Janssen Scientific Affairs, LLC. |
Keywords / Search Terms |
ACHL CME, CME/CE, Ruff, Christian Ruff, Brigham and Women's Hospital, Chronic Polyvascular Disease, PAD, CAD, MACE, PEGASUS, PRODIGY, COMPASS, CVD, DAPT, rivaroxaban, aspirin, CHARISMA, vlog, video blog, antithrombotic Free CE CME |